DS
DNA icon

David Shaw’s Ginkgo Bioworks DNA Stock Holding History

David Shaw’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.5M Buy
151,356
+124,187
+457% +$1.04M ﹤0.01% 3443
2026
Q1 		$167K Sell
27,169
-6,603
-20% -$54.9K ﹤0.01% 4231
2025
Q4 		$281K Buy
+33,772
New +$364K ﹤0.01% 4184
2025
Q3 		– Sell
-59,771
Closed -$715K – 4635
2025
Q2 		$672K Buy
+59,771
New +$463K ﹤0.01% 3490
2025
Q1 		– Sell
-546,418
Closed -$5.37M – 4365
2024
Q4 		$5.37M Sell
546,418
-326,233
-37% -$2.8M ﹤0.01% 1919
2024
Q3 		$7.11M Buy
872,651
+438,742
+101% +$4.4M 0.01% 1671
2024
Q2 		$5.8M Buy
433,909
+431,780
+20,281% +$12.9M 0.01% 1737
2024
Q1 		$98.8K Sell
2,129
-7,880
-79% -$408K ﹤0.01% 4009
2023
Q4 		$677K Buy
10,009
+9,740
+3,621% +$596K ﹤0.01% 3374
2023
Q3 		$19.5K Buy
+269
New +$21.5K ﹤0.01% 3994
2023
Q2 		– Sell
-270
Closed -$14.4K – 4301
2023
Q1 		$14.4K Sell
270
-390
-59% -$24.7K ﹤0.01% 4192
2022
Q4 		$44.6K Buy
+660
New +$60.7K ﹤0.01% 4450
2022
Q3 		– Sell
-285
Closed -$27K – 5257
2022
Q2 		$27K Sell
285
-55,009
-99% -$6.71M ﹤0.01% 4952
2022
Q1 		$8.91M Buy
55,294
+48,137
+673% +$9.37M 0.01% 1703
2021
Q4 		$2.38M Sell
7,157
-15,198
-68% -$7.22M ﹤0.01% 3198
2021
Q3 		$10.4M Buy
+22,355
New +$10.9M 0.01% 1489

Other funds holding DNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

David Shaw's DNA Position: Q2 2026 in Review

David Shaw increased its Ginkgo Bioworks (DNA) stake by 457% in Q2 2026, buying an estimated $1.04M and bringing the position to 151,356 shares worth $1.5M. The position accounts for ﹤0.01% of the portfolio, ranked #3443.

David Shaw first reported a position in DNA in Q3 2021 and has held it in 16 quarters since. The position peaked at $10.4M in Q3 2021. 183 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

  • David Shaw held 151,356 shares of Ginkgo Bioworks worth $1.5M as of Q2 2026.
  • David Shaw bought 124,187 Ginkgo Bioworks shares in Q2 2026, an estimated $1.04M.
  • Ginkgo Bioworks made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #3443 holding.
  • David Shaw first reported a position in Ginkgo Bioworks in Q3 2021 and has held it in 16 quarters since.
  • David Shaw's Ginkgo Bioworks position peaked at $10.4M in Q3 2021.
  • 183 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.